» Articles » PMID: 15013948

Incidence of Breast Cancer in Norway and Sweden During Introduction of Nationwide Screening: Prospective Cohort Study

Overview
Journal BMJ
Specialty General Medicine
Date 2004 Mar 12
PMID 15013948
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether any increase in the incidence of breast cancer in women detected by mammography is compensated for by a drop in the incidence after age 69, years when women are no longer invited for screening.

Design: Population based cohort study of incidence of breast cancer during the introduction of nationwide screening programmes.

Setting: Norway and Sweden.

Participants: All women aged above 30 years (1.4 and 2.9 million, respectively, in 2000).

Main Outcome Measures: Changes in age specific incidence rates of invasive breast cancer associated with the introduction of the screening programmes.

Results: As a result of screening the recorded incidence of breast cancer in women aged 50-69 years increased by 54% in Norway and 45% in Sweden. There was no corresponding decline in incidence after the age of 69 years.

Conclusions: Without screening one third of all invasive breast cancers in the age group 50-69 years would not have been detected in the patients' lifetime. This level of overdiagnosis is larger than previously reported.

Citing Articles

Significantly reduced incidence and improved survival from prostate cancer over 25 years.

Serda-Ferrer B, Sanvisens A, Fuentes-Raspall R, Puigdemont M, Farre X, Vidal-Vila A BMC Public Health. 2023; 23(1):2552.

PMID: 38129873 PMC: 10734155. DOI: 10.1186/s12889-023-17440-7.


Breast Cancer Screening: Is There Room for De-escalation?.

Kim L, Lannin D Curr Breast Cancer Rep. 2022; 14(4):153-161.

PMID: 36404936 PMC: 9640864. DOI: 10.1007/s12609-022-00465-z.


Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why?.

Chaltiel D, Hill C BMJ Open. 2021; 11(6):e046353.

PMID: 34158298 PMC: 8220464. DOI: 10.1136/bmjopen-2020-046353.


Poor Biological Factors and Prognosis of Interval Breast Cancers: Long-Term Results of Bahçeşehir (Istanbul) Breast Cancer Screening Project in Turkey.

Cabioglu N, Gurdal S, Kayhan A, Ozaydin N, Sahin C, Can O JCO Glob Oncol. 2020; 6:1103-1113.

PMID: 32678710 PMC: 7392766. DOI: 10.1200/GO.20.00145.


A Multi-million Mammography Image Dataset and Population-Based Screening Cohort for the Training and Evaluation of Deep Neural Networks-the Cohort of Screen-Aged Women (CSAW).

Dembrower K, Lindholm P, Strand F J Digit Imaging. 2019; 33(2):408-413.

PMID: 31520277 PMC: 7165146. DOI: 10.1007/s10278-019-00278-0.


References
1.
Hakama M, Pukkala E, Soderman B, Day N . Implementation of screening as a public health policy: issues in design and evaluation. J Med Screen. 2000; 6(4):209-16. DOI: 10.1136/jms.6.4.209. View

2.
Olsen O, Gotzsche P . Cochrane review on screening for breast cancer with mammography. Lancet. 2001; 358(9290):1340-2. DOI: 10.1016/S0140-6736(01)06449-2. View

3.
Etzioni R, Penson D, Legler J, di Tommaso D, Boer R, Gann P . Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002; 94(13):981-90. DOI: 10.1093/jnci/94.13.981. View

4.
Harmer C, Staples M, Kavanagh A . Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?. Cancer Causes Control. 1999; 10(5):333-7. DOI: 10.1023/a:1008949819969. View

5.
Thornton H, Edwards A, Baum M . Women need better information about routine mammography. BMJ. 2003; 327(7406):101-3. PMC: 1126456. DOI: 10.1136/bmj.327.7406.101. View